The murine nonclassical class I major histocompatibility complex-like CD1.1 Molecule protects target cells from lymphokine-activated killer cell cytolysis

Journal of Experimental Medicine

Volumn 189, Issue 3, 1999, Pages 483-491

  Chang, Chew Shun ^a   Brossay, Laurent ^b   Kronenberg, Mitchell ^b   Kane, Kevin P ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

CD1; Lymphokine activated killer cell; Lysis; Natural killer cells; Resistance

Indexed keywords

CD1-1 ANTIGEN; CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOLYSIS; FEMALE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOKINE ACTIVATED KILLER CELL; MOLECULAR DYNAMICS; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY MECHANISM; SPLEEN CELL; STRAIN DIFFERENCE;

ANIMALS; ANTIGENS, CD1; CYTOTOXICITY, IMMUNOLOGIC; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; KILLER CELLS, LYMPHOKINE-ACTIVATED; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RECEPTORS, IMMUNOLOGIC;

EID: 0344527957     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.3.483     Document Type: Article

References (55)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
2. Ortaldo, J.R., and D.L. Longo. 1988. Human natural lymphocyte effector cells: definition, analysis of activity, and clinical effectiveness J. Natl. Cancer Inst. 80:999-1009.
3. Orange, J.S., B. Wang, C. Terhorst, and C.A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration J. Exp. Med. 182:1045-1056.
4. Biron, C.A. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24-34.
5. Ljunggren, H.G., and K. Kärre. 1990. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol. Today. 11:237-244.
6. Höglund, P., J. Sundbäck, M.Y. Olsson-Alheim, M. Johannson, M. Salcedo, C. Öhlén, H.-G. Ljunggren, C.L. Sentman, and K. Kärre. 1997. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol. Rev. 155: 11-28.
7. Kärre, K., H.G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature. 319: 675-678.
8. Kaufman, D.S., R.A. Schoon, and P.J. Leibson. 1993. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. J. Immunol. 150:1429-1436.
9. Lanier, L.L., and J.H. Phillips. 1996. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today. 17:86-91.
10. Lanier, L.L. 1997. Natural killer cells: from no receptors to too many. Immunity. 6:371-378.
11. Reyburn, H., O. Mandelboim, M. Valés-Goméz, E.G. Sheu, L. Pazmany, D.M. Davis, and J.L. Strominger. 1997. Human NK cells: their ligands, receptors and functions. Immunol. Rev. 155:119-125.
12. Kane, K.P. 1994. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J. Exp. Med. 179:1011-1015.
13. Daniels, B.F., F.M. Karlhofer, W.E. Seaman, and W.M. Yokoyama. 1994. A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J. Exp. Med. 180:687-692.
14. + IL-2 activated natural killer cells. Nature. 358:66-70.
15. Moretta, A., M. Vitale, C. Bottino, A.M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta. 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178:597-604.
16. Colonna, M., and J. Samaridis. 1995. Cloning of Ig-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:405-408.
17. Shawar, S.M., J.M. Vyas, J.R. Rodgers, and R.R. Rich. 1994. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12:839-880.
18. Beckman, E.M., and M.B. Brenner. 1995. MHC class I-like, class II-like and CD1 molecules: distinct roles in immunity. Immunol. Today. 16:349-352.
19. Hughes, A.L. 1991. Evolutionary origin and diversification of the mammalian CD1 antigen genes. Mol Biol. Evol. 8:185-201.
20. Calabi, F., J.M. Jarvis, L. Martin, and C. Milstein. 1989. Two classes of CD1 genes. Eur. J. Immunol. 19:285-292.
21. Brutkiewicz, R.R., J.R. Bennink, J.W. Yewdell, and A. Bendelac. 1995. TAP-independent, β-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 182:1913-1919.
22. Teitell, M., H.R. Holcombe, L. Brossay, A. Hagenbaugh, M.J. Jackson, L. Pond, S.P. Balk, C. Terhorst, P.A. Peterson, and M. Kronenberg. 1997. Nonclassical behavior of the mouse CD1 class I-like molecule. J. Immunol. 158:2143-2149.
23. Zeng, Z.-H., A.R. Castaño, B.W. Segelke, E.A. Stura, P.A. Peterson, and I.A. Wilson. 1997. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science. 277:339-345.
24. + T lymphocytes. Science. 268:863-865.
25. + T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 159:2240-2249.
26. Castaño, A.R., S. Tangri, J.E.W. Miller, H.R. Holcombe, M.R. Jackson, W.D. Huse, M. Kronenberg, and P.A. Peterson. 1995. Peptide binding and presentation by mouse CD1. Science. 269:223-226.
27. + T cells. Science. 372: 691-698.
28. Sieling, P.A., D. Chatterjee, S.A. Porcelli, T.I. Prigozy, R.J. Mazzaccaro, T. Sorino, B.R. Bloom, M.B. Brenner, M. Kronenberg, P.J. Brennan, and R.L. Modlin. 1995. CD-1 restricted T cell recognition of microbial lipoglycan antigens. Science. 269:227-230.
29. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Kondo, H. Koseki, and M.M. Taniguchi. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 278:1626-1629.
30. + NK T lymphocytes. J. Immunol. 161:3271-3281.
31. Braud, V.M., D.S.J. Allan, C.A. O'Callaghan, K. Söderström, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Science. 391:795-799.
32. Borrego, F., M. Ulbrecht, E.H. Weiss, J.E. Coligan, and A.G. Brooks. 1998. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexes with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer-mediated lysis. J. Exp. Med. 187:813-818.
33. Colonna, M., J. Samaridis, M. Cella, L. Angman, R.L. Allen, C.A. O'Callaghan, R. Dunbar, G.S. Ogg, V. Cerundolo, and A. Rolink. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160:3096-3100.
34. Brossay, L., D. Jullien, S. Cardell, B.C. Sydora, N. Burdin, R.L. Modlin, and M. Kronenberg. 1997. Mouse CD1 is mainly expressed on hematopoietic-derived cells. J. Immunol. 159:1216-1224.
35. Kane, K.P., and M.F. Mescher. 1993. Activation of CD8-dependent cytotoxic T lymphocyte adhesion and degranulation by peptide class I antigen complexes. J. Immunol. 150: 4788-4797.
36. Gunji, Y., N.L. Vujanovic, J.C. Hiserodt, R.B. Herberman, and E. Gorelik. 1989. Generation and characterization of purified adherent lymphokine-activated killer cells in mice. J. Immunol. 142:1748-1754.
37. Mombaerts, P., J. Iacomini, R.S. Johnson, K. Herrup, S. Tonegawa, and V.E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Immunity. 68: 869-877.
38. Lee, D.J., A. Abeyratne, D.A. Carson, and M. Corr. 1998. Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response in vivo. J. Exp. Med. 187:433-438.
39. Storkus, W.J., M. Wei, P. Cresswell, and J.R. Dawson. 1996. Class I-like CD1A-C do not protect target cells from NK-mediated cytolysis. Cell. Immunol. 167:154-156.
40. Bradbury, A., K.T. Belt, T.M. Neri, C. Milstein, and F. Calabi. 1988. Mouse CD1 is distinct from and co-exists with TL in the same thymus. EMBO (Eur. Mol. Biol. Organ.) J. 7:3081-3086.
41. Park, S., J.H. Roark, and A. Bendelac. 1998. Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 160:3128-3134.
42. Salcedo, M., A.D. Diehl, M.Y. Olsson-Alheim, J. Sundbäck, L.V. Kaer, K. Kärre, and H.-G. Ljunggren. 1997. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J. Immunol. 158:3174-3180.
43. Esquivel, F., J. Yewdell, and J. Bennink. 1992. RMA/S cells present endogenously synthesized cytosolic protein to class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 175:163-168.
44. Hosken, N.A., and M. Bevan. 1992. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S J. Exp. Med. 175:719-729.
45. Brossay, L., N. Burdin, S. Tangri, and M. Kronenberg. 1998. Antigen-presenting function of mouse CD1 (mCD1): one molecule with two different kinds of antigen ligands. Immunol. Rev. 163:133-144.
46. - cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and development intermediates. J. Exp. Med. 186:1609-1614.
47. lo target cells: evidence for a Ly-49-independent negative signaling receptor. Eur. J. Immunol. 27:3100-3104.
48. Manoussaka, M.S., R.J. Smith, V. Conlin, J.A. Toomey, and C.G. Brooks. 1998. Fetal NK cell clones are deficient in Ly49 expression, share a common broad lytic specificity, and undergo continuous and extensive diversification in vitro. J. Immunol. 160:2197-2206.
49. Vance, R.E., D.M. Tanamachi, T. Hanke, and D.H. Raulet. 1997. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur. J. Immunol. 27:3236-3241.
50. Wang, L.L., I.K. Mehta, P.A. LeBlanc, and W.M. Yokoyama. 1997. Mouse natural killer cells express gp49B1, a structural homologue of human killer inhibitory receptors. J. Immunol. 158:13-17.
51. Joyce, S., A.S. Woods, J.W. Yewdell, J.R. Bennink, A.D. De Silva, A. Boesteanu, S.P. Balk, R.J. Cotter, and R.R. Brutkiewicz. 1998. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science. 279:1541-1544.
52. Correa, I., and D.H. Raulet. 1995. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity. 2:61-71.
53. + cells. J. Immunol. 160:1158-1165.
54. Ferrini, S., A. Cambiaggi, R. Meazza, S. Sforzini, S. Marciano, M.C. Mingari, and L. Moretta. 1994. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24:2294-2298.
55. Bendelac, A., M.N. Rivera, S.-H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.